tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Protara Therapeutics, Inc. (TARA) Q2 Earnings Cheat Sheet
PremiumPre-EarningsProtara Therapeutics, Inc. (TARA) Q2 Earnings Cheat Sheet
21d ago
Protara Therapeutics announces addition to Russell 3000 Idex
Premium
The Fly
Protara Therapeutics announces addition to Russell 3000 Idex
2M ago
Protara Therapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
Protara Therapeutics Holds Annual Stockholders Meeting
3M ago
Protara Therapeutics: Buy Rating Affirmed Amid Promising Clinical Data and Strong Financial Position
PremiumRatingsProtara Therapeutics: Buy Rating Affirmed Amid Promising Clinical Data and Strong Financial Position
4M ago
Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC with Strong Efficacy and Safety Profile
Premium
Ratings
Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC with Strong Efficacy and Safety Profile
4M ago
Protara Therapeutics appoints Nicacio as CMO, Williams as CPO
Premium
The Fly
Protara Therapeutics appoints Nicacio as CMO, Williams as CPO
4M ago
Protara Therapeutics: Promising Clinical Progress and Strong Buy Rating Amid Encouraging ADVANCED-2 Study Results
PremiumRatingsProtara Therapeutics: Promising Clinical Progress and Strong Buy Rating Amid Encouraging ADVANCED-2 Study Results
4M ago
Protara Therapeutics Reports Positive Phase 2 Trial Results
Premium
Company Announcements
Protara Therapeutics Reports Positive Phase 2 Trial Results
4M ago
Protara Therapeutics initiated with an Outperform at Scotiabank
Premium
The Fly
Protara Therapeutics initiated with an Outperform at Scotiabank
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100